Study Takes Measure Of Supplement Size And Link To Swallowing Problems

FDA and CDC Analysis of the 20,791 adverse event reports for vitamins, minerals and supplements from 2006 through 2015 found that 3,962, 19.1%, indicated swallowing problems and the 10 products most commonly identified in the reports all exceeded 17 mm, or 0.67 inch, in length.

Pill-big-smal

Manufacturers should consider limiting dietary supplement dimensions to less than three-quarters of an inch to help consumers, particularly elderly persons, swallow the products more easily, say US public health agency researchers.

An analysis of the 20,791 adverse event reports for vitamin, mineral and supplement products submitted to the Food and Drug Administration from 2006 through 2015 found that 3,962, 19.1%, indicated...

More from Strategy

More from Business

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By 

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By 

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.